Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Roche acquires PathAI for ~$1.05 billion

Swiss-based multinational healthcare company Roche has agreed to acquire PathAI, a US-based AI-powered digital pathology firm, for ~$1.05 billion. Roche will pay $750 million upfront and additional milestone payments of up to $300 million.

HBI 2026: Procurement Summit — Procurement as a value creation driver

Hospitals, facing increased pressure on their budgets, are turning to procurement as a strategic lever for cost control and resilience. At HBI 2026, as part of the Procurement Summit, panellists explored how hospitals can drive value creation through smarter procurement. 

HBI Deals+Insights briefing May 2026: Deals + Insights members

HBI’s May 2026 edition looks at global healthcare deals including Barmer partnering with Hello Inside, Affidea leaving Hungary, Doctolib buying Medicus and expanding into the UK, Medtronic investing in Pulnovo, among others. plus interviews and HBI 2026 post-conference write-ups.

HBI Deals+Insights briefing May 2026: Intelligence members

HBI’s May 2026 edition looks at global healthcare deals including Barmer partnering with Hello Inside, Affidea leaving Hungary, Doctolib buying Medicus and expanding into the UK, Medtronic investing in Pulnovo, among others. plus interviews and HBI 2026 post-conference write-ups.

ArchiMed to take Esperion private for ~$1 billion

French private equity firm ArchiMed is taking Nasdaq-listed commercial biopharma firm Esperion Therapeutics private for ~$1 billion. Esperion develops cardiometabolic and rare/orphan disease therapies.

Carlyle acquires Knack RCM and EqualizeRCM

US private equity firm Carlyle has acquired a majority stake in two healthcare revenue cycle management (RCM) platforms: Knack RCM and EqualizeRCM. The investment is being made through Carlyle Asia Partners VI and Carlyle Asia Partners Growth II.

Find Us